Course offering number:0812-201
Course ID:
541
Granulation, Tabletting and Capsule Technology
December 8-11, 2008
New Brunswick, NJ
Dr. Cecil W. Propst; Director R&D, SPI Pharma Group, Grand Haven
Dr. Cecil W. Propst is Director of R&D for SPI Pharma (Grand
Haven site), a processor of a variety of specialty ingredients for
the food, drug, cosmetic and related industries. He was
Director of Quality Assurance and Technical Development at
Fleming and Company and before that, President of
Manufacturing Chemists. His duties included system design,
product and process development, and regulatory affairs.
Previously, he served as cGMP Facilities Director for the
University of Maryland at Baltimore in connection with the
University’s contract with the FDA.
Dr. Propst also served as Director of Technical Development
for Stellar Manufacturing, Director of Quality Compliance for
SmithKline Beecham, Director of Quality Assurance for Norcliff
Thayer (a Revlon Company), Group Leader/Product
Development and Manager/ Quality Control for Lewis Howe
Company. He consults with TabTech for the chemical,
diagnostic, food, engineering and beverage industries.
|